The approval of Rabeprazole Sodium for the treatment of GERD by the US FDA is not big news for DRL as the approvals for the same drug has been granted to about 6-10 companies and its sold in USA by J&J with annual sales of USD 800 Million in the entire last year. Now since the patent has gone
4.33 PM Nov 11th 2013
Follow moneycontrol.comFacebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window Windows 8
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.